Pharmafile Logo
Pharmafocus logo
Advanced Search

BioNTech

Showing 15 posts of 22 posts found.

BioNTech and Autolus announce CAR T-cell therapy collaboration

February 9, 2024
Research and Development Autolus, BioNTech, CAR T-cell, Oncology, collaboration

BioNTech and Autolus Therapeutics have announced that they have entered a strategic collaboration intended to further both companies’ autologous CAR …

News

BioNTech achieves milestone at vaccine manufacturing site in Rwanda

December 19, 2023
Manufacturing and Production BioNTech, Immunology, manufacturing, rwanda

BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in …

News

BioNTech and CEPI partner for development of mRNA mpox vaccine

September 19, 2023
Research and Development BioNTech, CEPI, Immunology, mpox

BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advance the development of mRNA-based vaccine …

News

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021
Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …

News
Pfizer sign

Pfizer commences process for full FDA approval of COVID-19 vaccine

May 10, 2021
Sales and Marketing BioNTech, COVID-19 vaccine, FDA, Pfizer, Pfizer vaccine, pharma, pharma news

Pfizer and BioNTech have begun a Biologics Licence Application (BLA) with the FDA for full approval of their mRNA COVID-19 …

News
Pfizer's Lipitor tablet

Pfizer vaccine 91.3% effective after six months, Phase III study shows

April 6, 2021
Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine

Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …

News
1

EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe

December 1, 2020
Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …

News
fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020
Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …

News
vaccination-1215279_960_720

Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s

November 18, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …

News
512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …

News
shutterstock_2

Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine

November 13, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel

Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …

News
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020
Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …

News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …

News
shutterstock_2

Japan reserves 120m doses of BioNTech’s COVID-19 vaccine

July 31, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …

News
vaccination-1215279_960_720

BioNTech’s melanoma vaccine shows promise in early interim analysis

July 30, 2020
Research and Development BioNTech, Cancer, pharma

While the company has more recently drawn headlines for its COVID-19 efforts, BioNTech has unveiled promising interim Phase 1 data …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024